Correlation of Serum Uric Acid with Glycemic Indices of Diabetes Mellitus Subjects

Authors

  • Matthew Eturhobore Adu University of Delta

DOI:

https://doi.org/10.2659/njbmb.2022.20

Keywords:

Type 2 Diabetes Mellitus, glycosylated hemoglobin, cardiovascular risk, fasting blood sugar, uric acid

Abstract

Diabetes mellitus is a metabolic disease associated with hyperglycemia and patients are at an increased risk of nephropathy, retinopathy and other diabetic complications. The present study was carried out to evaluate the correlation of uric acid with glycemic indices and possibly as a surrogate glycemic biomarker in diabetes mellitus. A total of one hundred (100) individuals were recruited for the study comprising of eighty (80) known diabetic and twenty (20) apparently healthy individuals. After an overnight fast, blood samples were collected and separated. Fasting blood sugar, HbA1C and uric acid were estimated using standard methods. Diabetes mellitus subjects exhibit a significantly (p<0.05) higher fasting blood sugar level than apparently healthy subjects. Also, the diabetes mellitus subjects showed a significantly (p<0.05) higher glycosylated haemoglobin and serum uric acid when compared with apparently healthy subjects but there was no gender difference observed among the diabetes mellitus subjects. There was a positive association between serum uric acid and fasting blood sugar as well as glycosylated haemoglobin. Uric acid showed positive association and significant correlation with fasting blood sugar and glycosylated haemoglobin. Thus serum uric acid may be a potential surrogate glycemic biomarker in diabetes mellitus.

References

Adebisi, S.A., Oghagbon, E.K., Akande, T.M. and Olarinoye, J.K. (2009). Glycated haemoglobin and glycemic control of diabetics in Ilorin. Nigerian Journal of Clinical Practice, 12(1), 87-91.

Alam, R., Verma, M.K. and Verma, P. (2015). Glycated hemoglobin as a dual biomarker in type 2 diabetes mellitus predicting glycemic control and dyslipidemia risk. International Journal of Life-Sciences Scientific Research, 1(2), 62-65.

Dehghan, A., van Hoek, M., Sijbrands, E. J., Hofman, A. and Witteman, J. C. (2008). High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care, 31(2), 361–362.

Delamater, A.M. (2006). Clinical use of hemoglobin A1c to improve diabetes management. Clinical Diabetes, 24(1), 6-8.

Facchini, F., Chen, Y. D., Hollenbeck, C. B. and Reaven, G. M. (1991). Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. The Journal of the American Medical Association, 266(21), 3008–3011.

Feldt-Rasmussen, B. (2006). Is there a need to optimize glycemic control in hemodialyzed diabetic patients? Kidney International, 70(8), 1392–1394.

Hamwi, A., Schweiger, C.R., Veitl, M. and Schmid, R. (1995). Quantitative measurement of HbA1c by an immunoturbidimetric assay compared to a standard HPLC method. American Journal of Clinical Pathology, 104(1), 89-95.

Kageyama, N. (1971). A direct colorimetric determination of uric acid in serum and urine with uricase –catalase system. Clinica Chimica Acta, 31(2), 421- 426.

Kertes, P.J. (2013). Evidence based eye care. Philadelphia. Lippincott Williams and Wilkins, Pp 448

Khaw, K. T. and Wareham, N. (2006). Glycated hemoglobin as a marker of cardiovascular risk. Current Opinion in Lipidology, 17(6), 637–643.

Lima WGS, Martins-Santos MES, Chaves VE (2015): Uric acid as a modulator of glucose and lipid metabolism. Biochimie, 116: 17-23.

Lv, Q., Meng, X. F., He, F. F., Chen, S., Su, H., Xiong, J., Gao, P., Tian, X. J., Liu, J. S., Zhu, Z. H., Huang, K., & Zhang, C. (2013). High serum uric acid and increased risk of type 2 diabetes: a systemic review and meta-analysis of prospective cohort studies. PloS One, 8(2), e56864.

Michael, J. F. (2008). Microvascular and macrovascular complications of diabetes. Clinical Diabetes, 26(2), 77-82.

Modan, M., Halkin, H., Karasik, A. and Lusky, A. (1987). Elevated serum uric acid: a facet of hyperinsulinaemia. Diabetologia, 30(9), 713–718.

Momin, A.A., Bankar, M.P. and Bhoite, G.M. (2013). Glycosylated hemoglobin (HbA1C): association with dyslipidemia and predictor of cardiovascular diseases in type 2 diabetes mellitus patients. International Journal of Health Science Research, 3(8), 40-46.

Nakanishi, N., Okamoto, M., Yoshida, H., Matsuo, Y., Suzuki, K. and Tatara, K. (2003). Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers. European Journal of Epidemiology, 18(6), 523–530.

Qiu Q,Gong Y, Liu X, […] and Liang J (2015). Serum uric acid and impaired glucose tolerance: The Cardiometabolic Risk in Chinese (CRC) Study, Cell Biochemistry and Biophysics, 73(1):55–162.

Sarkar, A., Dash, S., Barik, B. K., Muttigi, M. S., Kedage, V., Shetty, J. K. and Prakash, M. (2010). Copper and ceruloplasmin levels in relation to total thiols and GST in type 2 diabetes mellitus patients. Indian Journal of Clinical Biochemistry, 25(1), 74–76.

Sluijs, I., Beulens, J.W.J, van der, D.L., Spijkerman A.M.W., Schulze, M.B. and Van Der, S.Y.T. (2013). Plasma uric acid is associated with increased risk of type 2 diabetes independent of diet and metabolic risk factors. The Journal of Nutrition, 143(1), 80–85.

Solano, F., Briganti, S., Picardo, M. and Ghanem, G. (2006). Hypopigmenting agents: an updated review on biological, chemical and clinical aspects. Pigment Cell Research, 19(6), 550–571.

Stolar, M. (2010). Glycemic control and complications in type 2 diabetes mellitus. The American Journal of Medicine, 123(3 Suppl), S3–S11.

Expert committee on the diagnosis and classification of diabetes mellitus (2003). Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes care, 26 Suppl 1, S5–S20.

Trinder, P. (1969). Determination of blood glucose using an oxidase – peroxidase system with a non- carcinogenic chromogen. Journal of Clinical Pathology, 22(2), 158-161.

Towfighi, A. (2011). Insulin resistance, obesity, metabolic syndrome and lifestyle modification. Continuum, 17(6), 1293-1303

Unadike, B.C., Eregie, A. and Ohwovoriole, A.E. (2011). Prevalence of hypertension amongst persons with diabetes mellitus in Benin city, Nigeria. Nigeria Journal of Clinical Practice, 14 (3), 300-302.

Xue, B., Tan, J. B., Ning, F., Sun, J. P., Zhang, K. Y., Liu, L., Wang, S. J., Zhang, D. F., Qiao, Q. and Pang, Z. C. (2015). Association between serum uric acid and prevalence of type 2 diabetes diagnosed using HbA1c criteria among Chinese adults in Qingdao, China. Biomedical and Environmental Sciences, 28(12), 884–893.

Published

2022-03-31

How to Cite

Adu, M. E. (2022). Correlation of Serum Uric Acid with Glycemic Indices of Diabetes Mellitus Subjects. Nigerian Journal of Biochemistry and Molecular Biology, 37(1), 82–86. https://doi.org/10.2659/njbmb.2022.20